Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Wow! I've been holding this stock for 49 weeks, not once did I think this would be @ $0.00009... I have to laugh because my average is only @ 0.00033 only down 99.69% with 102,000,000 shares. well on a positive note I'll have long-term gains/losses AKA (bag holder) on August 1st.
Rockie101, you do realize that June 23, 2023, will/is be/the 7th of 10 extensions? The final extension allowed will be September 23, 2023, with the conclusion of this SPAC deal coming to a close no later than October 23, 2023... Keeping in mind that this can all be settled/finalized at any time before October 23, 2023.
Enzolytics is continuing to make progress on the definitive agreement for the business combination with Sagaliam Acquisition Corp. Sagaliam recently announced the funding of its fifth extension. The date by which Sagaliam has to complete its business combination has been extended from April 23, 2023, to May 23, 2023. The Extension is the fifth of ten one-month extensions permitted under Sagaliam's governing documents and provides the Company with additional time to complete its business combination.
The way I understand the above post is that September 23, 2023, is the last and finale extension allotted for this SPAC, meaning a deal must be signed, seal & completed no later than October 23,2023.
Bonnie, that's the way I see it. If nothing happens with SAGA by the end of September, the window for the SPAC deal will close, however SAGA does have till October 23,2023 to finalize the deal. Leaving ENZC right where they were before the SPAC deal became known of.
No where did I read that the testing would start in May, What I read stated that Dr. Z would be going to Africa in May to demonstrate how to administer the drug ITV-1, I further went on to read that the testing will start in late July/early August. The testing consists of 2 jabs a week for 8 weeks followed by 1 week off the jabs, followed by another 8 weeks with 2 jabs a week for a total of 17 weeks of testing. Testing should be done sometime in mid/late-November 2023.
No, simply put ENZC still needs the A/F for 2022 in order to uplist & be SEC reporting... The two most recent completed years are needed for uplisting.
Question? Why has the timeline changed with the administration of ITV-1 in Africa?
Earlier this year it was stated by ENZC that the process would take 9 weeks, starting with 2 jabs a week for 28 days, followed by 1 week off treatment, then resuming with 2 jabs a week for 28 days.
Now the process seems to be a 17-week administration of ITV-1 with no known details of how ITV-1 is being administered.
Is anyone up to date as to why the change?
I posted this question on May 31, 2023 (178253)
I have a question, It may or may not be of concern.
How long does the current audited financials remain current before they need to be reaudited/made more current in order to be submitted to the SEC for uplisting.
I received this response, which I believe to be correct...
sspalmo
Re: all the way up green post# 178253
Wednesday, May 31, 2023, 5:48:51 PM
Post#
178267
of 178447
The audited financials should remain current indefinitely, unless the credibility of the auditors or the company providing the information comes into question. If I recall correctly in order to uplist, I believe it is the prior 2 years that need to be audited. 2022 has not been audited, so they cannot currently submit for uplisting.
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------So, with the above being said, ENZC doesn't have the 2 most current years of Finacial's being audited, they would need to include the year 2022. In addition, they would need to be submitted to the SEC prior to the SEC's deadline for submitting within the year of 2023.
What was left out from the above, is that ENZC received the audited financials for 2020/2021 on or around Dec.16th, 2022 and did not make the deadline for uplisting with the SEC within the year of 2022.
I have a question, it may or may not be of any concern.
How long do the current audited financials remain current before they need to be reaudited/made more current in order to be submitted to the SEC for uplisting?
TYIA...
How sad is this?
I'm sitting here crying to myself over the manipulation of how ENZC stock is trading... at the same time having suicidal thoughts going through my head.
Every time I decide to buy more shares, ENZC retreats back 50%, leaving me yet again a larger bag holder, I can't even flip out of this shit due the fact that I'm over 75% in the red.
Now I lay me down to sleep, I pray the lord my sole to keep, If I die before I wake, I pray the lord my sole to take.
Amen
Maga, thank you for referring to my post from 5/15/23... I'm glad to see people taking notice of it.
Am I missing something? Isn't there to be a Twist announcement today after hours, that may or may not involve ENZC in regard to a Gold Standard to Antibody Discoveries. I would have expected some FOMO (fear of missing out) trading today based on the rumor alone...
What if???... ENZC is using SAGA as a steppingstone and testing the waters out first, by selling BEGN & VIRO to SAGA to see if SAGA can maintain their share price above $10.+. Once SAGA proves themselves to ENZC, ENZC then does a reverse merger with SAGA, with ENZC being the surviving company and achieving their goal of being a NASDAQ listed company, by no means am I a financial adviser, however I play one on TV.
I'd rather have the gaps fill now as we are still low in price, as opposed to waiting till we're above say .20c-.30c... Just say' in.
I currently see ENZC dropping to fill the gap @ .085's, which will reset the RSI in the high 30's low 40's, by achieving this will tighten/recoil the ENZC spring to move forward. GLTA...
I know everyone here hates it when I say this, however ENZC does have that gap to fill around $0.0858c... we'll see if it fills.
I love days like today. I took advantage of the dip and added another 58K split between my 401-K & traditional accounts, I'm looking forward to the future of ENZC...
LoL! I was born in 1966. Is that young/old enough to get into the club.
Arclilles, GF was around a few days ago, he most post on Twitter & Discord.
Trust me I'm not complaining, only 0.14c sits between me being RED or Green... My inner self is telling me I'll be Green by months end, if not by the end of this week first. Only time will tell. GLTA!
I'm north of 1&1/4M...
Sid, Dave said that he and the company were going into a quiet period once the R/S took place. At no time did Dave say when the quiet period would end.
How about the bipolar Whale, one could always tell when she was flipping... she always went negative after she flipped out of ENZC.
I wouldn't mind seeing Gypsie come back and post, She's a world full of knowledge.
$3.00 sounds great, However I'd be happy getting to 0.30c first... Just say'in.
I'm a little confused in regard to dividends.
1) with the expected dividend, is it to come out of the $250M from SAGA? or,
2) with the expected dividend, is it to be additional payout from SAGA? or,
3) with the expected dividend, is to be paid with the recent delusion by ENZC.
TIA...
https://twitter.com/bowzachary/status/1643408755164614657/photo/1
I'm still trying to connect the dots here.
Different name and different company, refer to my earlier post #172859. company name is Monoclonal Antibody Therapeutics, Inc, shows Dr.CC as current director as of March 01,2023
https://twitter.com/bowzachary/status/1643303733277913089/photo/2
Could this be a possible name change for the company?
With the threat of a nuclear war buy the dip ahead of the first bomb dropping, If there's no nuclear war, you're ahead... If there is a nuclear war, well you won't need your money. Just say 'in.
Rockie, 3rd party can mean a lot of things... By no means am I saying this is what it is, however ENZC could be waiting to hear from Onelavi to see how much IPF they sold in Q4. 3rd party may also be in the form of any of the unknown NDA partners that may be involved with ENZC. This is all a guessing game at this time.
The 2.8B shares are outstanding shares.
The 3.9B shares are (a/s) authorized shares, big difference... The A/S shares have not been used/sold/purchased as of yet, ENZC holds those a/s shares to use as needed in the future.
$ENZC Just a reminder, from 2/08/23 news: Enzolytics' Chief Science Officer, Harry Zhabilov, manages the manufacture of ITV-1 and will travel to Africa in late March to confer with principals regarding the administration of the therapeutic to patients.
https://seekingalpha.com/pr/19110994-enzolytics-announces-preliminary-results-of-glp-toxicology-study-for-anti-hiv-therapeutic
Note: nowhere in this article does it say that the treatment will start anytime soon...
The Dr. is just going to Africia to confer the treatment method.
Enzolytics is anticipating entry into the markets of Rwanda, DR Congo, Botswana, and Kenya. Enzolytics' Chief Science Officer, Harry Zhabilov,
Does anyone here think ENZC will reach 0.25c or higher this year?
Yea, to bad I'm still down 80.75%. with an average of .24337... someday I'll be in the green.
I've been holding and accumulating since 2/03/21. total of 1,235,000 shares.
I received my order from One Lavi 2 weeks ago and the box has no seal, and the bottle doesn't have any tamper proof seal.
Falon, here's a copy and paste of the post. there was conversation ongoing for about an hour starting with post # 171421.
Catpole
Member Leve
Re: Capt_Smith77 post# 171417
Wednesday, March 08, 2023 10:31:34 AM
Post#
171421
of 171503
Expected $1,000 for treatment (considerably less than Gilead) with a goal of treating 45,000 in the first year. A significant revenue stream!
I have an honest question, and by no means am I trying to suggest anything. I'm just looking for clarification... Someone. earlier today posted the cost of ITV-1 in Africa will be $1,000.00.
My questions are as follows.
(1) Is the $1,000.00 for the 28 days/month or per injections, 2 per week for 28 days/month?
and then the patient takes 4 weeks off the treatment.
(2) Does the patient then start the whole process again paying another $1,000.00?
(3) Is this a lifelong therapeutic?
TIA